Related Experiment Video
Updated: Aug 25, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
Using the Cyclotide Scaffold for Targeting Biomolecular Interactions in Drug Development
Binu Jacob1, Alicia Vogelaar1, Enrique Cadenas1
1Department of Pharmacology and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 9033, USA.
Cyclotides are promising peptide scaffolds for drug development, offering a unique molecular framework for targeting challenging protein-protein interactions. Molecular techniques like epitope grafting enhance their therapeutic potential.
Area of Science:
- Biochemistry
- Medicinal Chemistry
- Molecular Biology
Background:
- Disrupting protein-protein interactions is difficult due to large, flat binding sites.
- Cyclotides offer a constrained polypeptide scaffold with cell-permeability.
- This scaffold shows promise for targeting complex biomolecular interactions.
Purpose of the Study:
- To review the properties of cyclotides.
- To explore their potential in developing novel peptide-based therapeutics.
- To highlight methods for selecting bioactive cyclotides.
Main Methods:
- Review of existing literature on cyclotide properties and applications.
- Discussion of molecular techniques such as epitope grafting.
- Exploration of molecular evolution strategies using the cyclotide scaffold.
Main Results:
- Cyclotides possess unique structural properties suitable for drug design.
- The cyclotide scaffold can be engineered to target protein-protein interactions.
- Epitope grafting and molecular evolution are effective for identifying bioactive cyclotides.
Conclusions:
- Cyclotides represent a promising scaffold for peptide-based therapeutics.
- Targeting protein-protein interactions can be advanced using cyclotide engineering.
- Further research into cyclotide-based drug development is warranted.
More Related Videos
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
08:48Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
Published on: January 26, 2016
Related Concept Videos
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Drug Discovery: Overview
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Protein-protein Interfaces
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include: